Market Analysis and Insights: Global Veterinary Pharmaceuticals Market
The global Veterinary Pharmaceuticals market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary Pharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary Pharmaceuticals market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary Pharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary Pharmaceuticals market.
Global Veterinary Pharmaceuticals Scope and Market Size
The global Veterinary Pharmaceuticals market size is projected to reach US$ 54.6 billion by 2023, from US$ 31.2 billion in 2029, at a CAGR of 7.3% during 2021-2023.
he research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Veterinary Biological Drugs
- Veterinary Preparations
- Others
Segment by Application
By Region
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
By Company
- Zoetis(Pfizer)
- MERIAL
- Merial
- Lilly
- Bayer
- Boehringer
- Novartis
- Virbac
- Ceva
- Vetoquinol
- CAHIC
- Ringpu
- Dahuanong
- TECON
- BIOK
- Lukang Pharma
- JINYU Group
- China Animal Healthcare
- Jiangxi Yiling
- JIZHONG Pharmaceutical
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Veterinary Pharmaceuticals product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Veterinary Pharmaceuticals, with price, sales, revenue, and global market share of Veterinary Pharmaceuticals from 2019 to 2022.
Chapter 3, the Veterinary Pharmaceuticals competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Veterinary Pharmaceuticals market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Pharmaceuticals.
Chapter 13, 14, and 15, to describe Veterinary Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Veterinary Pharmaceuticals Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
TABLE OF CONTENTS
1 Veterinary Pharmaceuticals Market Overview
1.1 Product Overview and Scope of Veterinary Pharmaceuticals
1.2 Veterinary Pharmaceuticals Segment by Type
1.2.1 Global Veterinary Pharmaceuticals Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Veterinary Biological Drugs
1.2.3 Veterinary Preparations
1.2.4 Others
1.3 Veterinary Pharmaceuticals Segment by Application
1.3.1 Global Veterinary Pharmaceuticals Sales Comparison by Application: (2022-2028)
1.3.2 Poultry
1.3.3 Pets
1.3.4 Other
1.4 Global Veterinary Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Veterinary Pharmaceuticals Revenue 2017-2028
1.4.2 Global Veterinary Pharmaceuticals Sales 2017-2028
1.4.3 Veterinary Pharmaceuticals Market Size by Region: 2017 Versus 2021 Versus 2028
2 Veterinary Pharmaceuticals Market Competition by Manufacturers
2.1 Global Veterinary Pharmaceuticals Sales Market Share by Manufacturers (2017-2022)
2.2 Global Veterinary Pharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Veterinary Pharmaceuticals Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Veterinary Pharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Veterinary Pharmaceuticals Market Competitive Situation and Trends
2.5.1 Veterinary Pharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Veterinary Pharmaceuticals Players Market Share by Revenue
2.5.3 Global Veterinary Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Pharmaceuticals Retrospective Market Scenario by Region
3.1 Global Veterinary Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Veterinary Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Veterinary Pharmaceuticals Market Facts & Figures by Country
3.3.1 North America Veterinary Pharmaceuticals Sales by Country
3.3.2 North America Veterinary Pharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Veterinary Pharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Veterinary Pharmaceuticals Sales by Country
3.4.2 Europe Veterinary Pharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Veterinary Pharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Veterinary Pharmaceuticals Sales by Region
3.5.2 Asia Pacific Veterinary Pharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Veterinary Pharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Veterinary Pharmaceuticals Sales by Country
3.6.2 Latin America Veterinary Pharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Veterinary Pharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Veterinary Pharmaceuticals Sales by Country
3.7.2 Middle East and Africa Veterinary Pharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Veterinary Pharmaceuticals Historic Market Analysis by Type
4.1 Global Veterinary Pharmaceuticals Sales Market Share by Type (2017-2022)
4.2 Global Veterinary Pharmaceuticals Revenue Market Share by Type (2017-2022)
4.3 Global Veterinary Pharmaceuticals Price by Type (2017-2022)
5 Global Veterinary Pharmaceuticals Historic Market Analysis by Application
5.1 Global Veterinary Pharmaceuticals Sales Market Share by Application (2017-2022)
5.2 Global Veterinary Pharmaceuticals Revenue Market Share by Application (2017-2022)
5.3 Global Veterinary Pharmaceuticals Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Zoetis(Pfizer)
6.1.1 Zoetis(Pfizer) Corporation Information
6.1.2 Zoetis(Pfizer) Description and Business Overview
6.1.3 Zoetis(Pfizer) Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Zoetis(Pfizer) Veterinary Pharmaceuticals Product Portfolio
6.1.5 Zoetis(Pfizer) Recent Developments/Updates
6.2 MERIAL
6.2.1 MERIAL Corporation Information
6.2.2 MERIAL Description and Business Overview
6.2.3 MERIAL Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.2.4 MERIAL Veterinary Pharmaceuticals Product Portfolio
6.2.5 MERIAL Recent Developments/Updates
6.3 Merial
6.3.1 Merial Corporation Information
6.3.2 Merial Description and Business Overview
6.3.3 Merial Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Merial Veterinary Pharmaceuticals Product Portfolio
6.3.5 Merial Recent Developments/Updates
6.4 Lilly
6.4.1 Lilly Corporation Information
6.4.2 Lilly Description and Business Overview
6.4.3 Lilly Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lilly Veterinary Pharmaceuticals Product Portfolio
6.4.5 Lilly Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Bayer Veterinary Pharmaceuticals Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Boehringer
6.6.1 Boehringer Corporation Information
6.6.2 Boehringer Description and Business Overview
6.6.3 Boehringer Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Boehringer Veterinary Pharmaceuticals Product Portfolio
6.6.5 Boehringer Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Veterinary Pharmaceuticals Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Corporation Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Virbac Veterinary Pharmaceuticals Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Ceva
6.9.1 Ceva Corporation Information
6.9.2 Ceva Description and Business Overview
6.9.3 Ceva Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Ceva Veterinary Pharmaceuticals Product Portfolio
6.9.5 Ceva Recent Developments/Updates
6.10 Vetoquinol
6.10.1 Vetoquinol Corporation Information
6.10.2 Vetoquinol Description and Business Overview
6.10.3 Vetoquinol Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Vetoquinol Veterinary Pharmaceuticals Product Portfolio
6.10.5 Vetoquinol Recent Developments/Updates
6.11 CAHIC
6.11.1 CAHIC Corporation Information
6.11.2 CAHIC Veterinary Pharmaceuticals Description and Business Overview
6.11.3 CAHIC Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.11.4 CAHIC Veterinary Pharmaceuticals Product Portfolio
6.11.5 CAHIC Recent Developments/Updates
6.12 Ringpu
6.12.1 Ringpu Corporation Information
6.12.2 Ringpu Veterinary Pharmaceuticals Description and Business Overview
6.12.3 Ringpu Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Ringpu Veterinary Pharmaceuticals Product Portfolio
6.12.5 Ringpu Recent Developments/Updates
6.13 Dahuanong
6.13.1 Dahuanong Corporation Information
6.13.2 Dahuanong Veterinary Pharmaceuticals Description and Business Overview
6.13.3 Dahuanong Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Dahuanong Veterinary Pharmaceuticals Product Portfolio
6.13.5 Dahuanong Recent Developments/Updates
6.14 TECON
6.14.1 TECON Corporation Information
6.14.2 TECON Veterinary Pharmaceuticals Description and Business Overview
6.14.3 TECON Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.14.4 TECON Veterinary Pharmaceuticals Product Portfolio
6.14.5 TECON Recent Developments/Updates
6.15 BIOK
6.15.1 BIOK Corporation Information
6.15.2 BIOK Veterinary Pharmaceuticals Description and Business Overview
6.15.3 BIOK Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.15.4 BIOK Veterinary Pharmaceuticals Product Portfolio
6.15.5 BIOK Recent Developments/Updates
6.16 Lukang Pharma
6.16.1 Lukang Pharma Corporation Information
6.16.2 Lukang Pharma Veterinary Pharmaceuticals Description and Business Overview
6.16.3 Lukang Pharma Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Lukang Pharma Veterinary Pharmaceuticals Product Portfolio
6.16.5 Lukang Pharma Recent Developments/Updates
6.17 JINYU Group
6.17.1 JINYU Group Corporation Information
6.17.2 JINYU Group Veterinary Pharmaceuticals Description and Business Overview
6.17.3 JINYU Group Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.17.4 JINYU Group Veterinary Pharmaceuticals Product Portfolio
6.17.5 JINYU Group Recent Developments/Updates
6.18 China Animal Healthcare
6.18.1 China Animal Healthcare Corporation Information
6.18.2 China Animal Healthcare Veterinary Pharmaceuticals Description and Business Overview
6.18.3 China Animal Healthcare Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.18.4 China Animal Healthcare Veterinary Pharmaceuticals Product Portfolio
6.18.5 China Animal Healthcare Recent Developments/Updates
6.19 Jiangxi Yiling
6.19.1 Jiangxi Yiling Corporation Information
6.19.2 Jiangxi Yiling Veterinary Pharmaceuticals Description and Business Overview
6.19.3 Jiangxi Yiling Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Jiangxi Yiling Veterinary Pharmaceuticals Product Portfolio
6.19.5 Jiangxi Yiling Recent Developments/Updates
6.20 JIZHONG Pharmaceutical
6.20.1 JIZHONG Pharmaceutical Corporation Information
6.20.2 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Description and Business Overview
6.20.3 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.20.4 JIZHONG Pharmaceutical Veterinary Pharmaceuticals Product Portfolio
6.20.5 JIZHONG Pharmaceutical Recent Developments/Updates
7 Veterinary Pharmaceuticals Manufacturing Cost Analysis
7.1 Veterinary Pharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Veterinary Pharmaceuticals
7.4 Veterinary Pharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Veterinary Pharmaceuticals Distributors List
8.3 Veterinary Pharmaceuticals Customers
9 Veterinary Pharmaceuticals Market Dynamics
9.1 Veterinary Pharmaceuticals Industry Trends
9.2 Veterinary Pharmaceuticals Market Drivers
9.3 Veterinary Pharmaceuticals Market Challenges
9.4 Veterinary Pharmaceuticals Market Restraints
10 Global Market Forecast
10.1 Veterinary Pharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Veterinary Pharmaceuticals by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Veterinary Pharmaceuticals by Type (2023-2028)
10.2 Veterinary Pharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Veterinary Pharmaceuticals by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Veterinary Pharmaceuticals by Application (2023-2028)
10.3 Veterinary Pharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Veterinary Pharmaceuticals by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Veterinary Pharmaceuticals by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Veterinary Pharmaceuticals Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Veterinary Pharmaceuticals Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Veterinary Pharmaceuticals Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Veterinary Pharmaceuticals Market Competitive Situation by Manufacturers in 2021
Table 5. Global Veterinary Pharmaceuticals Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Veterinary Pharmaceuticals Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Veterinary Pharmaceuticals Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Veterinary Pharmaceuticals Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Veterinary Pharmaceuticals Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Veterinary Pharmaceuticals Manufacturing Sites and Area Served
Table 11. Manufacturers Veterinary Pharmaceuticals Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Veterinary Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Pharmaceuticals as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Veterinary Pharmaceuticals Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Veterinary Pharmaceuticals Sales Market Share by Region (2017-2022)
Table 17. Global Veterinary Pharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Veterinary Pharmaceuticals Revenue Market Share by Region (2017-2022)
Table 19. North America Veterinary Pharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Veterinary Pharmaceuticals Sales Market Share by Country (2017-2022)
Table 21. North America Veterinary Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Veterinary Pharmaceuticals Revenue Market Share by Country (2017-2022)
Table 23. Europe Veterinary Pharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Veterinary Pharmaceuticals Sales Market Share by Country (2017-2022)
Table 25. Europe Veterinary Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Veterinary Pharmaceuticals Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Veterinary Pharmaceuticals Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Veterinary Pharmaceuticals Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Veterinary Pharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Veterinary Pharmaceuticals Revenue Market Share by Region (2017-2022)
Table 31. Latin America Veterinary Pharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Veterinary Pharmaceuticals Sales Market Share by Country (2017-2022)
Table 33. Latin America Veterinary Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Veterinary Pharmaceuticals Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Veterinary Pharmaceuticals Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Veterinary Pharmaceuticals Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Veterinary Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Veterinary Pharmaceuticals Revenue Market Share by Country (2017-2022)
Table 39. Global Veterinary Pharmaceuticals Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Veterinary Pharmaceuticals Sales Market Share by Type (2017-2022)
Table 41. Global Veterinary Pharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Veterinary Pharmaceuticals Revenue Share by Type (2017-2022)
Table 43. Global Veterinary Pharmaceuticals Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Veterinary Pharmaceuticals Sales (K Pcs) by Application (2017-2022)
Table 45. Global Veterinary Pharmaceuticals Sales Market Share by Application (2017-2022)
Table 46. Global Veterinary Pharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Veterinary Pharmaceuticals Revenue Share by Application (2017-2022)
Table 48. Global Veterinary Pharmaceuticals Price by Application (2017-2022) & (USD/Pcs)
Table 49. Zoetis(Pfizer) Corporation Information
Table 50. Zoetis(Pfizer) Description and Business Overview
Table 51. Zoetis(Pfizer) Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Zoetis(Pfizer) Veterinary Pharmaceuticals Product
Table 53. Zoetis(Pfizer) Recent Developments/Updates
Table 54. MERIAL Corporation Information
Table 55. MERIAL Description and Business Overview
Table 56. MERIAL Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. MERIAL Veterinary Pharmaceuticals Product
Table 58. MERIAL Recent Developments/Updates
Table 59. Merial Corporation Information
Table 60. Merial Description and Business Overview
Table 61. Merial Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Merial Veterinary Pharmaceuticals Product
Table 63. Merial Recent Developments/Updates
Table 64. Lilly Corporation Information
Table 65. Lilly Description and Business Overview
Table 66. Lilly Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Lilly Veterinary Pharmaceuticals Product
Table 68. Lilly Recent Developments/Updates
Table 69. Bayer Corporation Information
Table 70. Bayer Description and Business Overview
Table 71. Bayer Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Bayer Veterinary Pharmaceuticals Product
Table 73. Bayer Recent Developments/Updates
Table 74. Boehringer Corporation Information
Table 75. Boehringer Description and Business Overview
Table 76. Boehringer Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Boehringer Veterinary Pharmaceuticals Product
Table 78. Boehringer Recent Developments/Updates
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Business Overview
Table 81. Novartis Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Novartis Veterinary Pharmaceuticals Product
Table 83. Novartis Recent Developments/Updates
Table 84. Virbac Corporation Information
Table 85. Virbac Description and Business Overview
Table 86. Virbac Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Virbac Veterinary Pharmaceuticals Product
Table 88. Virbac Recent Developments/Updates
Table 89. Ceva Corporation Information
Table 90. Ceva Description and Business Overview
Table 91. Ceva Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Ceva Veterinary Pharmaceuticals Product
Table 93. Ceva Recent Developments/Updates
Table 94. Vetoquinol Corporation Information
Table 95. Vetoquinol Description and Business Overview
Table 96. Vetoquinol Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Vetoquinol Veterinary Pharmaceuticals Product
Table 98. Vetoquinol Recent Developments/Updates
Table 99. CAHIC Corporation Information
Table 100. CAHIC Description and Business Overview
Table 101. CAHIC Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. CAHIC Veterinary Pharmaceuticals Product
Table 103. CAHIC Recent Developments/Updates
Table 104. Ringpu Corporation Information
Table 105. Ringpu Description and Business Overview
Table 106. Ringpu Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. Ringpu Veterinary Pharmaceuticals Product
Table 108. Ringpu Recent Developments/Updates
Table 109. Dahuanong Corporation Information
Table 110. Dahuanong Description and Business Overview
Table 111. Dahuanong Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Dahuanong Veterinary Pharmaceuticals Product
Table 113. Dahuanong Recent Developments/Updates
Table 114. TECON Corporation Information
Table 115. TECON Description and Business Overview
Table 116. TECON Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. TECON Veterinary Pharmaceuticals Product
Table 118. TECON Recent Developments/Updates
Table 119. BIOK Corporation Information
Table 120. BIOK Description and Business Overview
Table 121. BIOK Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. BIOK Veterinary Pharmaceuticals Product
Table 123. BIOK Recent Developments/Updates
Table 124. Lukang Pharma Corporation Information
Table 125. Lukang Pharma Description and Business Overview
Table 126. Lukang Pharma Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Lukang Pharma Veterinary Pharmaceuticals Product
Table 128. Lukang Pharma Recent Developments/Updates
Table 129. JINYU Group Corporation Information
Table 130. JINYU Group Description and Business Overview
Table 131. JINYU Group Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. JINYU Group Veterinary Pharmaceuticals Product
Table 133. JINYU Group Recent Developments/Updates
Table 134. China Animal Healthcare Corporation Information
Table 135. China Animal Healthcare Description and Business Overview
Table 136. China Animal Healthcare Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. China Animal Healthcare Veterinary Pharmaceuticals Product
Table 138. China Animal Healthcare Recent Developments/Updates
Table 139. Jiangxi Yiling Corporation Information
Table 140. Jiangxi Yiling Description and Business Overview
Table 141. Jiangxi Yiling Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. Jiangxi Yiling Veterinary Pharmaceuticals Product
Table 143. Jiangxi Yiling Recent Developments/Updates
Table 144. JIZHONG Pharmaceutical Corporation Information
Table 145. JIZHONG Pharmaceutical Description and Business Overview
Table 146. JIZHONG Pharmaceutical Veterinary Pharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 147. JIZHONG Pharmaceutical Veterinary Pharmaceuticals Product
Table 148. JIZHONG Pharmaceutical Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Veterinary Pharmaceuticals Distributors List
Table 152. Veterinary Pharmaceuticals Customers List
Table 153. Veterinary Pharmaceuticals Market Trends
Table 154. Veterinary Pharmaceuticals Market Drivers
Table 155. Veterinary Pharmaceuticals Market Challenges
Table 156. Veterinary Pharmaceuticals Market Restraints
Table 157. Global Veterinary Pharmaceuticals Sales Forecast by Type (2023-2028) & (K Pcs)
Table 158. Global Veterinary Pharmaceuticals Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Veterinary Pharmaceuticals Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Veterinary Pharmaceuticals Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Veterinary Pharmaceuticals Sales Forecast by Application (2023-2028) & (K Pcs)
Table 162. Global Veterinary Pharmaceuticals Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Veterinary Pharmaceuticals Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Veterinary Pharmaceuticals Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Veterinary Pharmaceuticals Sales Forecast by Region (2023-2028) & (K Pcs)
Table 166. Global Veterinary Pharmaceuticals Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Veterinary Pharmaceuticals Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Veterinary Pharmaceuticals Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Pharmaceuticals
Figure 2. Global Veterinary Pharmaceuticals Market Share by Type in 2021 & 2028
Figure 3. Veterinary Biological Drugs Product Picture
Figure 4. Veterinary Preparations Product Picture
Figure 5. Others Product Picture
Figure 6. Global Veterinary Pharmaceuticals Market Share by Application in 2021 & 2028
Figure 7. Poultry
Figure 8. Pets
Figure 9. Other
Figure 10. Global Veterinary Pharmaceuticals Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Veterinary Pharmaceuticals Market Size (2017-2028) & (US$ Million)
Figure 12. Global Veterinary Pharmaceuticals Sales (2017-2028) & (K Pcs)
Figure 13. Veterinary Pharmaceuticals Sales Share by Manufacturers in 2021
Figure 14. Global Veterinary Pharmaceuticals Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Veterinary Pharmaceuticals Players: Market Share by Revenue in 2021
Figure 16. Veterinary Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Veterinary Pharmaceuticals Sales Market Share by Region (2017-2022)
Figure 18. Global Veterinary Pharmaceuticals Sales Market Share by Region in 2021
Figure 19. Global Veterinary Pharmaceuticals Revenue Market Share by Region (2017-2022)
Figure 20. Global Veterinary Pharmaceuticals Revenue Market Share by Region in 2021
Figure 21. U.S. Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Veterinary Pharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Veterinary Pharmaceuticals by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Veterinary Pharmaceuticals
Figure 47. Manufacturing Process Analysis of Veterinary Pharmaceuticals
Figure 48. Veterinary Pharmaceuticals Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
